Friday, February 01, 2019
MZ Digital Marketing Agency
from Reuters: Health News https://reut.rs/2SfFFd3
Friday, February 1, 2019
Friday, February 01, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
The U.S. Food and Drug Administration (FDA) approved Mylan NV's generic version of GlaxoSmithKline-developed blockbuster asthma treatment Advair, driving shares of Mylan 7 percent higher on Wednesday.
from Reuters: Health News https://reut.rs/2SfFFd3
from Reuters: Health News https://reut.rs/2SfFFd3
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment